Harmony Biosciences Holdings, Inc. ( HRMY) - Key Metrics
HRMY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $4.23 | $0.39 | -$3.85 | -$3.85 |
| 2025Q3 | $4.10 | $0.87 | $1.86 | $1.86 |
| 2025Q2 | $3.49 | $0.69 | $1.38 | $1.38 |
| 2025Q1 | $3.22 | $0.79 | $0.59 | $0.59 |
HRMY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 23.98 |
| 2025Q3 | ? | 7.92 |
| 2025Q2 | ? | 11.41 |
| 2025Q1 | ? | 10.44 |
HRMY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.71% | ? |
| 2025Q4 | 5.84% | ? |
| 2025Q3 | 6.74% | ? |
| 2025Q2 | 4.37% | ? |
| 2025Q1 | 1.78% | ? |
HRMY
Price: $34.18
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.48 USD
P/E Ratio: 12.16
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 87588
Market Capitalization: 1.9 billion